Adherence Affects Monocyte Innate Immune Function and Metabolic Reprogramming after Lipopolysaccharide Stimulation In Vitro.


Journal

Journal of immunology (Baltimore, Md. : 1950)
ISSN: 1550-6606
Titre abrégé: J Immunol
Pays: United States
ID NLM: 2985117R

Informations de publication

Date de publication:
15 02 2021
Historique:
received: 12 06 2020
accepted: 07 12 2020
pubmed: 8 1 2021
medline: 20 7 2021
entrez: 7 1 2021
Statut: ppublish

Résumé

Circulating nonadherent monocytes can migrate to extravascular sites by a process that involves adherence. Alterations in intracellular metabolism shape the immunological phenotype of phagocytes upon activation. To determine the effect of adherence on their metabolic and functional response human monocytes were stimulated with LPS under nonadherent and adherent conditions. Adherent monocytes (relative to nonadherent monocytes) produced less TNF and IL-1β (proinflammatory) and more IL-10 (anti-inflammatory) upon LPS stimulation and had an increased capacity to phagocytose and produce reactive oxygen species. RNA sequencing analysis confirmed that adherence modified the LPS-induced response of monocytes, reducing expression of proinflammatory genes involved in TLR signaling and increasing induction of genes involved in pathogen elimination. Adherence resulted in an increased glycolytic response as indicated by lactate release, gene set enrichment, and [

Identifiants

pubmed: 33408258
pii: jimmunol.2000702
doi: 10.4049/jimmunol.2000702
doi:

Substances chimiques

Lipopolysaccharides 0
Monokines 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

827-838

Informations de copyright

Copyright © 2021 by The American Association of Immunologists, Inc.

Auteurs

Natasja A Otto (NA)

Center for Experimental and Molecular Medicine, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands; n.a.otto@amsterdamumc.nl.
Amsterdam Infection and Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Joe M Butler (JM)

Center for Experimental and Molecular Medicine, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.
Amsterdam Infection and Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Ivan Ramirez-Moral (I)

Center for Experimental and Molecular Medicine, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.
Amsterdam Infection and Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Michel van Weeghel (M)

Laboratory Genetic Metabolic Diseases, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.
Core Facility Metabolomics, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.
Amsterdam Gastroenterology and Metabolism, 1105 AZ Amsterdam, the Netherlands.
Amsterdam Cardiovascular Sciences, 1105 AZ Amsterdam, the Netherlands.

Jeroen W J van Heijst (JWJ)

Neogene Therapeutics, 1098 XG Amsterdam, the Netherlands.

Brendon P Scicluna (BP)

Center for Experimental and Molecular Medicine, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.
Amsterdam Infection and Immunity Institute, 1105 AZ Amsterdam, the Netherlands.
Department of Clinical Epidemiology, Biostatistics and Bioinformatics, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands; and.

Riekelt H Houtkooper (RH)

Laboratory Genetic Metabolic Diseases, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.
Amsterdam Gastroenterology and Metabolism, 1105 AZ Amsterdam, the Netherlands.
Amsterdam Cardiovascular Sciences, 1105 AZ Amsterdam, the Netherlands.

Alex F de Vos (AF)

Center for Experimental and Molecular Medicine, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.
Amsterdam Infection and Immunity Institute, 1105 AZ Amsterdam, the Netherlands.

Tom van der Poll (T)

Center for Experimental and Molecular Medicine, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.
Amsterdam Infection and Immunity Institute, 1105 AZ Amsterdam, the Netherlands.
Division of Infectious Diseases, Amsterdam University Medical Centers, University of Amsterdam, 1105 AZ Amsterdam, the Netherlands.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH